Ruben A. Mesa, MD, FACP - CONTROL Myelofibrosis: Current Options, New Treatment Principles, and Opportunities to Leverage JAKi Platforms and Novel MOAs

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/MOC/AAPA/IPCE information, and to apply for
credit, please visit us at PeerView.com/AQJ865. CME/MOC/AAPA/IPCE
credit will be available until June 30, 2025.


CONTROL Myelofibrosis: Current Options, New Treatment Principles,
and Opportunities to Leverage JAKi Platforms and Novel MOAs


In support of improving patient care, PVI, PeerView Institute for
Medical Education, is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis educational activity is
supported by independent medical education grants from Bristol
Myers Squibb, Geron, GSK, and Incyte Corporation.


Disclosure information is available at the beginning of the video
presentation.